Use of psychotropic medications in adults with intellectual disability: A systematic review and meta-analysis.

Song, Menghuan; Rubin, Bryn S; Ha, Justin Wt; Ware, Robert S; Doan, Tan N; Harley, David

Song, Menghuan; Rubin, Bryn S; Ha, Justin Wt; Ware, Robert S; Doan, Tan N; Harley, David.

Affiliation

Song M; Queensland Centre for Intellectual and Developmental Disability (QCIDD), Mater Research Institute-University of Queensland (MRI-UQ), Mater Misericordiae Hospital, Brisbane, QLD, Australia.
Rubin BS; Ochsner Clinical School, University of Queensland, Brisbane, QLD, Australia.
Ha JW; Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
Ware RS; Queensland Centre for Intellectual and Developmental Disability (QCIDD), Mater Research Institute-University of Queensland (MRI-UQ), Mater Misericordiae Hospital, Brisbane, QLD, Australia.
Doan TN; Menzies Health Institute Queensland, Griffith University, Nathan, QLD, Australia.
Harley D; Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.

Aust N Z J Psychiatry ; 57(5): 661-674, 2023 05.

Article de En | MEDLINE | ID: mdl-36700564

Sujet(s)
Mots clés

Prevalence; intellectual disability; meta-analysis; psychotropic drugs; systematic review

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Neuroleptiques / Anxiolytiques / Stimulants du système nerveux central / Déficience intellectuelle Type d'étude: Risk_factors_studies / Systematic_reviews Limites: Adult / Humans Langue: En Journal: Aust N Z J Psychiatry Année: 2023 Type de document: Article Pays d'affiliation: Australie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google